Autistic epileptiform regression
2006-01-01 Canitano, R; Zappella, M
Three Rett patients with both MECP2 mutation and 15q11-13 rearrangements
2004-01-01 Longo, I; Russo, L; Meloni, I; Ricci, I; Ariani, F; Pescucci, C; Giordano, Ct; Canitano, R; Hayek, G; Zappella, M; Neri, G; Renieri, A; Gurrieri, F
Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency
2013-01-01 Soorya, L; Kolevzon, A; Zweifach, J; Lim, T; Dobry, Y; Schwartz, L; Frank, Y; Wang, At; Cai, Gq; Parkhomenko, E; Halpern, D; Grodberg, D; Angarita, B; Willner, Jp; Yang, A; Canitano, R; Chaplin, W; Betancur, C; Buxbaum, Jd
Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders
2020-01-01 Mochel, Fanny; Rastetter, Agnès; Ceulemans, Berten; Platzer, Konrad; Yang, Sandra; Shinde, Deepali N; Helbig, Katherine L; Lopergolo, Diego; Mari, Francesca; Renieri, Alessandra; Benetti, Elisa; Canitano, Roberto; Waisfisz, Quinten; Plomp, Astrid S; Huisman, Sylvia A; Wilson, Golder N; Cathey, Sara S; Louie, Raymond J; Gaudio, Daniela Del; Waggoner, Darrel; Kacker, Shawn; Nugent, Kimberly M; Roeder, Elizabeth R; Bruel, Ange-Line; Thevenon, Julien; Ehmke, Nadja; Horn, Denise; Holtgrewe, Manuel; Kaiser, Frank J; Kamphausen, Susanne B; Abou Jamra, Rami; Weckhuysen, Sarah; Dalle, Carine; Depienne, Christel
Glutamatergic agents in Autism Spectrum Disorders: Current trends
2014-01-01 Canitano, R; Scandurra, V
Autism spectrum disorders: An historical synthesis and a multidimensional assessment toward a tailored therapeutic program
2015-01-01 Xavier, J; Bursztejn, C; Stiskin, M; Canitano, R; Cohen, D
Excitation/Inhibition Modulators in Autism Spectrum Disorder: Current Clinical Research
2021-01-01 Canitano, R; Palumbi, R
Self injurious behavior in autism: clinical aspects and treatment with risperidone
2006-01-01 Canitano, R
Tics and Tourette syndrome in autism spectrum disorders
2007-01-01 Canitano, R; Vivanti, G
NADPH oxidase activation and 4-hydroxy-2-nonenal/aquaporin-4 adducts as possible new players in oxidative neuronal damage presents in drug-resistant epilepsy
2015-01-01 Pecorelli, A; Natrella, F; Belmonte, G; Miracco, C; Cervellati, F; Ciccoli, L; Mariottini, A; Rocchi, R; Vatti, G; Bua, A; Canitano, R; Hayek, J; Forman, Hj; Valacchi, G
Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects
2013-01-01 Cohen, D; Raffin, M; Canitano, R; Bodeau, N; Bonnot, O; Perisse, D; Consoli, A; Laurent, C
Clinical experience with Topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders
2005-01-01 Canitano, R
Epilepsy, electroencephalographic abnormalities, and regression in children with autism
2005-01-01 Canitano, R; Luchetti, A; Zappella, M
Dual copy number variants involving 16p11 and 6q22 in a case of childhood apraxia of speech and pervasive developmental disorder
2013-01-01 Newbury, Df; Mari, F; Akha, Es; Macdermot, Kd; Canitano, R; Monaco, Ap; Taylor, Jc; Renieri, A; Fisher, Se; Knight, Sjl
Epilepsy in autism spectrum disorders
2007-01-01 Canitano, R
Novel treatments in autism spectrum disorders: From synaptic dysfunction to experimental therapeutics
2013-01-01 Canitano, R
Exploring Self-Consciousness From Self- and Other-Image Recognition in the Mirror: Concepts and Evaluation
2019-01-01 Keromnes, G; Chokron, S; Celume, Mp; Berthoz, A; Botbol, M; Canitano, R; Du Boisgueheneuc, F; Jaafari, N; Lavenne-Collot, N; Martin, B; Motillon, T; Thirioux, B; Scandurra, V; Wehrmann, M; Ghanizadeh, A; Tordjman, S
New experimental treatments for core social domain in autism spectrum disorders
2014-01-01 Canitano, R
New treatment perspectives in autism spectrum disorders
2015-01-01 Canitano, R; Bozzi, Y
Editorial: Autism Spectrum Disorders: Developmental Trajectories, Neurobiological Basis, Treatment Update, Volume 2
2020-01-01 Canitano, R; Bozzi, Y; Dhossche, D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Autistic epileptiform regression | 1-gen-2006 | Canitano, R; Zappella, M | |
| Three Rett patients with both MECP2 mutation and 15q11-13 rearrangements | 1-gen-2004 | Longo, I; Russo, L; Meloni, I; Ricci, I; Ariani, F; Pescucci, C; Giordano, Ct; Canitano, R; Hayek, G; Zappella, M; Neri, G; Renieri, A; Gurrieri, F | |
| Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency | 1-gen-2013 | Soorya, L; Kolevzon, A; Zweifach, J; Lim, T; Dobry, Y; Schwartz, L; Frank, Y; Wang, At; Cai, Gq; Parkhomenko, E; Halpern, D; Grodberg, D; Angarita, B; Willner, Jp; Yang, A; Canitano, R; Chaplin, W; Betancur, C; Buxbaum, Jd | |
| Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders | 1-gen-2020 | Mochel, Fanny; Rastetter, Agnès; Ceulemans, Berten; Platzer, Konrad; Yang, Sandra; Shinde, Deepali N; Helbig, Katherine L; Lopergolo, Diego; Mari, Francesca; Renieri, Alessandra; Benetti, Elisa; Canitano, Roberto; Waisfisz, Quinten; Plomp, Astrid S; Huisman, Sylvia A; Wilson, Golder N; Cathey, Sara S; Louie, Raymond J; Gaudio, Daniela Del; Waggoner, Darrel; Kacker, Shawn; Nugent, Kimberly M; Roeder, Elizabeth R; Bruel, Ange-Line; Thevenon, Julien; Ehmke, Nadja; Horn, Denise; Holtgrewe, Manuel; Kaiser, Frank J; Kamphausen, Susanne B; Abou Jamra, Rami; Weckhuysen, Sarah; Dalle, Carine; Depienne, Christel | |
| Glutamatergic agents in Autism Spectrum Disorders: Current trends | 1-gen-2014 | Canitano, R; Scandurra, V | |
| Autism spectrum disorders: An historical synthesis and a multidimensional assessment toward a tailored therapeutic program | 1-gen-2015 | Xavier, J; Bursztejn, C; Stiskin, M; Canitano, R; Cohen, D | |
| Excitation/Inhibition Modulators in Autism Spectrum Disorder: Current Clinical Research | 1-gen-2021 | Canitano, R; Palumbi, R | |
| Self injurious behavior in autism: clinical aspects and treatment with risperidone | 1-gen-2006 | Canitano, R | |
| Tics and Tourette syndrome in autism spectrum disorders | 1-gen-2007 | Canitano, R; Vivanti, G | |
| NADPH oxidase activation and 4-hydroxy-2-nonenal/aquaporin-4 adducts as possible new players in oxidative neuronal damage presents in drug-resistant epilepsy | 1-gen-2015 | Pecorelli, A; Natrella, F; Belmonte, G; Miracco, C; Cervellati, F; Ciccoli, L; Mariottini, A; Rocchi, R; Vatti, G; Bua, A; Canitano, R; Hayek, J; Forman, Hj; Valacchi, G | |
| Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects | 1-gen-2013 | Cohen, D; Raffin, M; Canitano, R; Bodeau, N; Bonnot, O; Perisse, D; Consoli, A; Laurent, C | |
| Clinical experience with Topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders | 1-gen-2005 | Canitano, R | |
| Epilepsy, electroencephalographic abnormalities, and regression in children with autism | 1-gen-2005 | Canitano, R; Luchetti, A; Zappella, M | |
| Dual copy number variants involving 16p11 and 6q22 in a case of childhood apraxia of speech and pervasive developmental disorder | 1-gen-2013 | Newbury, Df; Mari, F; Akha, Es; Macdermot, Kd; Canitano, R; Monaco, Ap; Taylor, Jc; Renieri, A; Fisher, Se; Knight, Sjl | |
| Epilepsy in autism spectrum disorders | 1-gen-2007 | Canitano, R | |
| Novel treatments in autism spectrum disorders: From synaptic dysfunction to experimental therapeutics | 1-gen-2013 | Canitano, R | |
| Exploring Self-Consciousness From Self- and Other-Image Recognition in the Mirror: Concepts and Evaluation | 1-gen-2019 | Keromnes, G; Chokron, S; Celume, Mp; Berthoz, A; Botbol, M; Canitano, R; Du Boisgueheneuc, F; Jaafari, N; Lavenne-Collot, N; Martin, B; Motillon, T; Thirioux, B; Scandurra, V; Wehrmann, M; Ghanizadeh, A; Tordjman, S | |
| New experimental treatments for core social domain in autism spectrum disorders | 1-gen-2014 | Canitano, R | |
| New treatment perspectives in autism spectrum disorders | 1-gen-2015 | Canitano, R; Bozzi, Y | |
| Editorial: Autism Spectrum Disorders: Developmental Trajectories, Neurobiological Basis, Treatment Update, Volume 2 | 1-gen-2020 | Canitano, R; Bozzi, Y; Dhossche, D |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista38783
- 2 Contributo in Volume2
Data di pubblicazione
- In corso di stampa30
- 2020 - 202610551
- 2010 - 201912539
- 2000 - 20098046
- 1990 - 19995281
- 1980 - 19892072
- 1970 - 1979262
- 1966 - 19694
Editore
- EDP Sciences2
- Eliseo Ranzi, Katharina Kohse-Höi...2
- Humana Press Inc.2
- Wiley Online Library2
- Brill1
- Cambridge University Press: 20111
- Edizioni dell'U.M.I.1
- Elsevier1
- GIOVANNI COSTA1
- IFIP1
Rivista
- PHYSICAL REVIEW LETTERS179
- PLOS ONE150
- IEEE TRANSACTIONS ON ELECTROMAGNE...141
- L'INDUSTRIA DELLE COSTRUZIONI140
- APPLIED SCIENCES137
- PHYSICAL REVIEW. B, CONDENSED MAT...135
- INTERNATIONAL JOURNAL OF MOLECULA...131
- SCIENTIFIC REPORTS124
- TRANSPLANTATION PROCEEDINGS118
- ENERGIES106
Serie
- METHODS IN MOLECULAR BIOLOGY2
Keyword
- Humans1211
- Female618
- Male577
- Adult341
- Italy311
- Middle Aged300
- Aged247
- COVID-19240
- Neurology (clinical)227
- Child212
Lingua
- eng27801
- ita5262
- fre99
- spa97
- ger42
- lat9
- pol7
- por6
- rus6
- enm5
Accesso al fulltext
- no fulltext27058
- open8257
- restricted2453
- reserved922
- partially open89
- mixed4
- embargoed2